Salar Mousa: Effect of COVID-19 on Initiation of Antithrombotic Therapy Post-Stroke in Sweden
Salar Mousa, PHD Student at Örebro University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I am very excited to share our newly published study examining the effect of COVID-19 pandemic on the initiation of antithrombotic therapy after stroke in Sweden.
Published in Basic and Clinical Pharmacology and Toxicology.
I would like to sincerely thank my supervisors and co-authors from Örebro University, Uppsala University and Gothenburg University for their support and work on this project.”
Title: Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre- and Post–COVID-19 in Sweden—An Interrupted Time Series Study
Authors: Salar Mousa, Katarina Persson, Maria Palmetun-Ekbäck, Fredrik Nyberg, Huiqi Li, Björn Wettermark, Mohammad Hossein Hajiebrahimi
Read the Full Article on Basic and Clinical Pharmacology and Toxicology
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC